tykhr
sign in
free sign up
Viridian Therapeutics Inc
Biotechnology
Healthcare
VRDN
66.42 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
10.73
52 week high
25.71
high
11.92
52 week low
11.02
low
9.90
growth
-1.34 %
previous Close
11.02
P/E ratio
-10
market cap
1.53 B
div yield
0
usd
Sep 2024
qoq
revenue
86.00 K
19.44 %
net incoming
-76.69 M
-18.00 %
eps
-1.15 %
-13.20 %
eps surprise
-8.92 %
net profit margin
-89173.26 %
1094.00 %
operating incoming
-83.48 M
-15.64 %
net change in cash
92.65 M
478.12 %
cash on hand
200 M
86.05 %
cost of revenue
0.00 %
top